Skip to main content

MEDIFAST INC

For the period ended Sep 30, 2025. Filed Nov 3, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 3, 2025

MED$12.81+0.6%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. – Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(U.S. dollars in thousands, except per share amounts & dividend data)

Three months ended September 30,Nine months ended September 30,
2025202420252024
Revenue$89,409$140,163$310,692$483,460
Cost of sales27,25034,48987,645127,056
Gross profit62,159105,674223,047356,404
Selling, general, and administrative66,240103,568229,457354,235
Income (loss) from operations(4,081)2,106(6,410)2,169
Other income (expense)
Interest income1,4261,3334,0963,851
Other income (expense)(2)(1,861)3,057(3,508)
1,424(528)7,153343
Income (loss) before provision for income taxes(2,657)1,5787432,512
Provision (benefit) for income taxes(396)4491,2961,222
Net income (loss)$(2,261)$1,129$(553)$1,290
Earnings (loss) per share - basic$(0.21)$0.10$(0.05)$0.12
Earnings (loss) per share - diluted$(0.21)$0.10$(0.05)$0.12
Weighted average shares outstanding
Basic10,99110,93710,97710,928
Diluted10,99110,97110,97710,959

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

(U.S. dollars in thousands)

Three months ended September 30,Nine months ended September 30,
2025202420252024
Net income (loss)$(2,261)$1,129$(553)$1,290
Other comprehensive income, net of tax:
Foreign currency translation—4—47
Unrealized net gains on investment securities413194054
4132340101
Comprehensive income (loss)$(2,220)$1,452$(513)$1,391
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.